Ito Hiroshi, Sakata Kensuke, Haruki Takashi, Kobayashi Yurio
Department of Cardiovascular Surgery, Saiseikai Shimonoseki General Hospital, 8-5-1 Yasuoka, Shimonoseki, 759-6603, Yamaguchi, Japan.
J Cardiothorac Surg. 2011 Jul 5;6:88. doi: 10.1186/1749-8090-6-88.
The second-generation pericardial valve, the Carpentier-Edwards perimount bioprosthetic (CEP) valve, shows dramatically improved durability as compared to the first-generation pericardial valve, and excellent performance has been obtained, in both the aortic and mitral positions. Especially in elderly patients with an implanted CEP valve, reoperation due to structural valve deterioration (SVD) is rarely required. Here, we report the case of an 87-year-old woman with an explanted CEP valve in the mitral position due to SVD, 16 years after its implantation.
第二代心包瓣膜,即卡朋蒂埃-爱德华兹心包生物假体(CEP)瓣膜,与第一代心包瓣膜相比,耐用性显著提高,在主动脉和二尖瓣位置均表现出色。尤其是植入CEP瓣膜的老年患者,因瓣膜结构退化(SVD)而进行再次手术的情况很少见。在此,我们报告一例87岁女性患者,其二尖瓣位置植入的CEP瓣膜在植入16年后因SVD而被取出。